This knowledge is important for pathologists, clinicians and radiologists when interpreting PSMA/PET-CT scans from patients with prostate cancer, as this finding is apparently responsible for tracer uptake that must not been misinterpreted as prostate cancer metastasis. This evidence concerns the gene FOLH1 and prostate carcinoma.